Evidence map›Paper›PMID 36329095›Full record

ArticleScientific reports2022

Identifying high-risk population of depression: association between metabolic syndrome and depression using a health checkup and claims database.

Takahiro Imaizumi, Takuya Toda, Michitaka Maekawa, Daisuke Sakurai, Yuta Hagiwara, Yasuko Yoshida, Masahiko Ando, Shoichi Maruyama

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takahiro ImaizumiDepartment of Advanced Medicine, Nagoya University Hospital, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 464-8550, Japan. imaizumi18@med.nagoya-u.ac.jp.
Takuya TodaPrevent Co., Ltd., Nagoya, Japan.
Michitaka MaekawaHidamari Kokoro Clinic, Ama, Japan.
Daisuke SakuraiPrevent Co., Ltd., Nagoya, Japan.
Yuta HagiwaraPrevent Co., Ltd., Nagoya, Japan.
Yasuko YoshidaInnovative Research Center for Preventive Medical Engineering, Nagoya University, Nagoya, Japan.
Masahiko AndoDepartment of Advanced Medicine, Nagoya University Hospital, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 464-8550, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 464-8550, Japan. marus@med.nagoya-u.ac.jp.
Nagoya University · JPNagoya University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression and metabolic syndrome (MetS) are correlated, leading to an increased healthcare burden and decreased productivity. We aimed to investigate the association between MetS-related factors and depression using a health checkup and claims database. Individuals aged 18-75 years who underwent health examinations between 2014 and 2019 were enrolled in the study. Among 76,277 participants, "ever" and "incident" antidepressant users exhibited worse metabolic profiles and were more likely to be prescribed hypnotics and anxiolytics than "never" users. In a nested case-control study with a 1:10 ratio of incident users to controls, MetS was associated with incident antidepressant use (odds ratio, 1.53 [95% confidence interval 1.24-1.88]) adjusted for lifestyle information obtained from a self-administered questionnaire, medical history, and medications. Other metabolic traits also showed significant associations: body mass index (1.04 [1.02-1.06]), abdominal circumference per 10 cm (1.17 [1.08-1.27]), high blood pressure (1.17 [1.00-1.37]), glucose intolerance (1.29 [1.05-1.58]), and dyslipidemia (1.27 [1.08-1.51]). A bodyweight increase > 10 kg from age 20 years (1.46 [1.25-1.70]) was also significantly associated with incident antidepressant use. In conclusion, metabolic abnormalities were associated with incident antidepressant use and can be useful in identifying populations at high risk of depression.

Indexed as

Metabolic SyndromeBody Mass IndexCase-Control StudiesDepressionHumansRisk Factors

Identifiers

PMID36329095
PMCPMC9633757
OpenAlexW4308497553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.